AlphaMark Advisors’s Chemours CC Stock Holding History

AlphaMark Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-250	Closed	-$6K	–	702
2024 Q2	$6K	Buy	+250	New	+$6.55K	﹤0.01%	591

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

AlphaMark Advisors's CC Position: Q3 2024 in Review

AlphaMark Advisors sold out of Chemours (CC) in Q3 2024, closing a stake of 250 shares — an estimated $6K sold.

AlphaMark Advisors first reported a position in CC in Q2 2024 and held it in 1 quarter. The position peaked at $6K in Q2 2024. 421 funds tracked by Wall St. Rank hold CC as of Q3 2024.

AlphaMark Advisors reported no remaining Chemours position as of Q3 2024 after selling out during the quarter.
AlphaMark Advisors sold 250 Chemours shares in Q3 2024, an estimated $6K.
AlphaMark Advisors first reported a position in Chemours in Q2 2024 and held it in 1 quarter.
AlphaMark Advisors's Chemours position peaked at $6K in Q2 2024.
421 funds tracked by Wall St. Rank held Chemours as of Q3 2024.

Based on AlphaMark Advisors's 13F filing for Q3 2024, filed 16 Oct 2024.